GREENLAND MINES LTD (GRML) Debt Components
- 2025-03-31: Short-term DebtUSD (m); Notes Payable, CurrentUSD $1.77M; Convertible Notes Payable, CurrentUSD (m); Convertible Notes PayableUSD (m).
- 2024-12-31: Short-term DebtUSD (m); Notes Payable, CurrentUSD $240.75K; Convertible Notes Payable, CurrentUSD (m); Convertible Notes PayableUSD (m).
- 2024-06-30: Short-term DebtUSD (m); Notes Payable, CurrentUSD (m); Convertible Notes Payable, CurrentUSD $15.06K; Convertible Notes PayableUSD (m).
- 2024-03-31: Short-term DebtUSD (m); Notes Payable, CurrentUSD (m); Convertible Notes Payable, CurrentUSD (m); Convertible Notes PayableUSD (m).
GREENLAND MINES LTD Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Short-term Debt USD | Notes Payable, Current USD | Convertible Notes Payable, Current USD | Convertible Notes Payable USD | Long-term Debt, Fair Value USD | Debt Instrument, Redemption Price, Percentage pure | Notes Payable, Related Parties, Current USD |
|---|---|---|---|---|---|---|---|
| 2025-03-31 | (m) | $1.77M | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $240.75K | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | (m) | $15.06K | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | (m) | (m) | (m) | (m) | 3 month · 100.00% | (m) |
| 2023-12-31 | (m) | $1.31M | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | (m) | (m) | 12 month · 100.00% | (m) |
| 2023-09-30 | (m) | (m) | (m) | (m) | (m) | 9 month · 100.00% | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) | (m) | 6 month · 100.00% | (m) |
| 2023-06-30 | (m) | (m) | (m) | $870.00K | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) | (m) | 3 month · 100.00% | (m) |
| 2023-03-31 | (m) | (m) | (m) | $47.33K | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | (m) | (m) | 12 month · 100.00% | (m) |
| 2022-12-31 | (m) | (m) | (m) | (m) | $715.30K | (m) | (m) |
| 2022-11-30 | $300.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | 9 month · 100.00% | (m) |
| 2022-09-12 | (m) | $1.31M | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | 6 month · 100.00% | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | (m) | 3 month · 100.00% | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | $200.00K |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $8.51K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |